The global demand for Swine Vaccines Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period of 2022 - 2028.
Vaccines appear to induce protective immunity. It consists of antigens from viruses, bacterial toxins, bacteria, or parasites. Vaccines are injected into swine to accelerate an immune response, which will protect them against future infection with the organism. Swine vaccines can be live, containing living organisms that will multiply in the pig, or inactivated, consisting only killed organisms that will not multiply in the swine. Vaccines commonly used on pig includes E. coli diarrhea, clostridial dysentery of piglets, erysipelas, parvovirus infection, necrotic pleuropneumonia caused by Actinobacillus pleuropneumoniae, enzootic pneumonia caused by Mycoplasma hyopneumoniae, and atrophic rhinitis caused by toxigenic Pasteurella multocida.
Market Dynamics
An increase in pork consumption, escalating swine industry, and growing precautions taken to protect swine from epidemics and other threats drive the demand for swine vaccines worldwide. Rising pork consumption has given rise to a growing need to keep the swine free from every possible disease that could affect swine and threaten the human population. The growth of infection, epidemics, and intensive pig operations has made effective vaccination imperative in the swine industry. Outbreaks of diseases such as porcine respiratory and reproductive syndrome (PRRS) and porcine epidemic diarrhea have caused massive losses. These are controlled by vaccinating pregnant sows. There has also been growth in R&D expenditure for the innovation of unmet disease vaccines. However, high expenses of maintaining and handling storage conditions and the chance of a reverse reaction from vaccines are projected to impede the growth of global swine vaccines.
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each segment in the global market of swine vaccines.
Market Segmentation
This section of the swine vaccines market report provides detailed data on the segments by analyzing them geographically, thereby assisting the strategist in identifying the target demographics for the respective product or service.
By Target Disease
- Diarrhea
- Swine Influenza
- Arthritis
- Bordetella Rhinitis
- Porcine Reproductive and Respiratory Syndrome (PRRS)
- Porcine Circovirus Associated Disease (PCVAD)
- Other Target Diseases
By Technology
- Inactivated Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- Others
By End User
- Veterinary Hospitals
- Hog Production Farms
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for Swine Vaccines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Swine Vaccines Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the swine vaccines market include Ceva Santé Animale, Boehringer Ingelheim GmbH, Merck & Co., Inc., Elanco, Zoetis, Bayer AG, IDT Biologika GmbH, HIPRA, Ceva Sante Animale, Arko Laboratories Ltd. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.1. Objective
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Market
2.2. Global Market Snapshot
3 . SWINE VACCINES – INDUSTRY ANALYSIS
3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter’s Five Force Analysis
3.7. Market Attractiveness Analysis
3.7.1 By Target Disease
3.7.2 By Technology
3.7.3 By End User
3.7.4 By Region
4 . VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Raw Material Manufactures List
4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
5.1. Impact Analysis of Covid-19 Outbreak
5.1.1. Direct Impact on Production
5.1.2. Supply Chain and Market Disruption
5.1.3. Financial Impact on Firms and Financial Markets
5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
5.3. Market: Pre V/S Post COVID-19
5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
5.5. COVID-19: Micro and Macro Factor Analysis
6 . GLOBAL SWINE VACCINES MARKET ANALYSIS BY TARGET DISEASE
6.1 Overview by Target Disease
6.2 Historical and Forecast Data
6.3 Analysis by Target Disease
6.4 Diarrhea Market by Regions
6.5 Swine Influenza Market by Regions
6.6 Arthritis Market by Regions
6.7 Bordetella Rhinitis Market by Regions
6.8 Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Regions
6.9 Porcine Circovirus Associated Disease (PCVAD) Market by Regions
6.10. Other Target Diseases Market by Regions
7 . GLOBAL SWINE VACCINES MARKET ANALYSIS BY TECHNOLOGY
7.1 Overview by Technology
7.2 Historical and Forecast Data
7.3 Analysis by Technology
7.4 Inactivated Vaccines Market by Regions
7.5 Live Attenuated Vaccines Market by Regions
7.6 Toxoid Vaccines Market by Regions
7.7 Recombinant Vaccines Market by Regions
7.8 Others Market by Regions
8 . GLOBAL SWINE VACCINES MARKET ANALYSIS BY END USER
8.1 Overview by End User
8.2 Historical and Forecast Data
8.3 Analysis by End User
8.4 Veterinary Hospitals Market by Regions
8.5 Hog Production Farms Market by Regions
9 . GLOBAL SWINE VACCINES MARKET ANALYSIS BY GEOGRAPHY
9.1. Regional Outlook
9.2. Introduction
9.3. North America
9.3.1. Overview, Historic and Forecast Data
9.3.2. North America By Segment
9.3.3. North America By Country
9.3.4. United State
9.3.5. Canada
9.3.6. Mexico
9.4. Europe
9.4.1. Overview, Historic and Forecast Data
9.4.2. Europe by Segment
9.4.3. Europe by Country
9.4.4. United Kingdom
9.4.5. France
9.4.6. Germany
9.4.7. Italy
9.4.8. Russia
9.4.9. Rest Of Europe
9.5. Asia Pacific
9.5.1. Overview, Historic and Forecast Data
9.5.2. Asia Pacific by Segment
9.5.3. Asia Pacific by Country
9.5.4. China
9.5.5. India
9.5.6. Japan
9.5.7. South Korea
9.5.8. Australia
9.5.9. Rest Of Asia Pacific
9.6. Latin America
9.6.1. Overview, Historic and Forecast Data
9.6.2. Latin America by Segment
9.6.3. Latin America by Country
9.6.4. Brazil
9.6.5. Argentina
9.6.6. Peru
9.6.7. Chile
9.6.8. Rest of Latin America
9.7. Middle East & Africa
9.7.1. Overview, Historic and Forecast Data
9.7.2. Middle East & Africa by Segment
9.7.3. Middle East & Africa by Country
9.7.4. Saudi Arabia
9.7.5. UAE
9.7.6. Israel
9.7.7. South Africa
9.7.8. Rest Of Middle East And Africa
10 . COMPETITIVE LANDSCAPE OF THE SWINE VACCINES COMPANIES
10.1. Swine Vaccines Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments
11 . COMPANY PROFILES OF SWINE VACCINES INDUSTRY
11.1. Company Share Analysis
11.2. Market Concentration Rate
11.3. Ceva Santé Animale
11.3.1. Company Overview
11.3.2. Financials
11.3.3. Products
11.3.4. Recent Developments
11.4. Boehringer Ingelheim GmbH
11.4.1. Company Overview
11.4.2. Financials
11.4.3. Products
11.4.4. Recent Developments
11.5. Merck & Co., Inc.
11.5.1. Company Overview
11.5.2. Financials
11.5.3. Products
11.5.4. Recent Developments
11.6. Elanco
11.6.1. Company Overview
11.6.2. Financials
11.6.3. Products
11.6.4. Recent Developments
11.7. Zoetis
11.7.1. Company Overview
11.7.2. Financials
11.7.3. Products
11.7.4. Recent Developments
11.8. Bayer AG
11.8.1. Company Overview
11.8.2. Financials
11.8.3. Products
11.8.4. Recent Developments
11.9. IDT Biologika GmbH
11.9.1. Company Overview
11.9.2. Financials
11.9.3. Products
11.9.4. Recent Developments
11.10. HIPRA
11.10.1. Company Overview
11.10.2. Financials
11.10.3. Products
11.10.4. Recent Developments
11.11. Ceva Sante Animale
11.11.1. Company Overview
11.11.2. Financials
11.11.3. Products
11.11.4. Recent Developments
11.12. Arko Laboratories Ltd.
11.12.1. Company Overview
11.12.2. Financials
11.12.3. Products
11.12.4. Recent Developments
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
LIST OF TABLES
- Market Snapshot
- Drivers : Impact Analysis
- Restraints : Impact Analysis
- List of Raw Material
- List of Raw Material Manufactures
- List of Potential Buyers
- COVID-19 Impact Analysis by Production, Import, Export and Demand
- Pre V/S Post COVID-19
- Estimated Impact Of The Coronavirus (Covid-19) Epidemic
- COVID-19: Micro and Macro Factor Analysis
- Analysis by Target Disease (USD MN)
- Diarrhea Market by Geography (USD MN)
- Swine Influenza Market by Geography (USD MN)
- Arthritis Market by Geography (USD MN)
- Bordetella Rhinitis Market by Geography (USD MN)
- Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Geography (USD MN)
- Porcine Circovirus Associated Disease (PCVAD) Market by Geography (USD MN)
- Other Target Diseases Market by Geography (USD MN)
- Analysis Market by Technology (USD MN)
- Inactivated Vaccines Market by Geography (USD MN)
- Live Attenuated Vaccines Market by Geography (USD MN)
- Toxoid Vaccines Market by Geography (USD MN)
- Recombinant Vaccines Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Analysis by End User (USD MN)
- Veterinary Hospitals Market by Geography (USD MN)
- Hog Production Farms Market by Geography (USD MN)
- Global Swine Vaccines Market by Geography (USD MN)
- North America Market Analysis (USD MN)
- United State Market Analysis (USD MN)
- Canada Market Analysis (USD MN)
- Mexico Market Analysis (USD MN)
- Europe Market Analysis (USD MN)
- Europe Market Estimate by Country (USD MN)
- United Kingdom Market Analysis (USD MN)
- France Market Analysis (USD MN)
- Germany Market Analysis (USD MN)
- Italy Market Analysis (USD MN)
- Russia Market Analysis (USD MN)
- Spain Market Analysis (USD MN)
- Rest of Europe Market Analysis (USD MN)
- Asia Pacific Market Analysis (USD MN)
- China Market Analysis (USD MN)
- Japan Market Analysis (USD MN)
- India Market Analysis (USD MN)
- South Korea Market Analysis (USD MN)
- Australia Market Analysis (USD MN)
- Rest of Asia Pacific Market Analysis (USD MN)
- Latin America Market Analysis (USD MN)
- Brazil Market Analysis (USD MN)
- Argentina Market Analysis (USD MN)
- Peru Market Analysis (USD MN)
- Chile Market Analysis (USD MN)
- Rest of Latin America Market Analysis (USD MN)
- Middle East & Africa Market Analysis (USD MN)
- Saudi Arabia Market Analysis (USD MN)
- UAE Market Analysis (USD MN)
- Israel Market Analysis (USD MN)
- South Africa Market Analysis (USD MN)
- Rest of Middle East and Africa Market Analysis (USD MN)
- Partnership/Collaboration/Agreement
- Mergers And Acquisiton
LIST OF FIGURES
- Research Scope of Swine Vaccines Report
- Market Research Process
- Market Research Methodology
- Global Swine Vaccines Market Size, by Region (USD MN)
- Porters Five Forces Analysis
- Market Attractiveness Analysis by Target Disease
- Market Attractiveness Analysis by Technology
- Market Attractiveness Analysis by End User
- Market Attractiveness Analysis by Region
- Value Chain Analysis
- Global Market Analysis by Target Disease (USD MN)
- Diarrhea Market by Geography (USD MN)
- Swine Influenza Market by Geography (USD MN)
- Arthritis Market by Geography (USD MN)
- Bordetella Rhinitis Market by Geography (USD MN)
- Porcine Reproductive and Respiratory Syndrome (PRRS) Market by Geography (USD MN)
- Porcine Circovirus Associated Disease (PCVAD) Market by Geography (USD MN)
- Other Target Diseases Market by Geography (USD MN)
- Global Market Analysis by Technology (USD MN)
- Inactivated Vaccines Market by Geography (USD MN)
- Live Attenuated Vaccines Market by Geography (USD MN)
- Toxoid Vaccines Market by Geography (USD MN)
- Recombinant Vaccines Market by Geography (USD MN)
- Others Market by Geography (USD MN)
- Global Market Analysis by End User (USD MN)
- Veterinary Hospitals Market by Geography (USD MN)
- Hog Production Farms Market by Geography (USD MN)
- Global Market by Revenue
- North America Market by Revenue
- Europe Market by Revenue
- Asia Pacific Market by Revenue
- Latin America Market by Revenue
- Middle East & Africa Market by Revenue
- Recent Development in Industry
- Company Market Share Analysis
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.